This is the authors' abstract. We don't add key points for this paper.
Introduction Dexmedetomidine is a specific agonist of the α2-adrenergic receptor [1]. Unlike other sedatives it has both sedative and analgesic effects [2]. It can dramatically reduce post-operative requirements for analgesics [3]. Used alone, its combined analgesic/sedative effect makes it a preferred drug for awake craniotomy [4-7]. Recently, it has attracted considerable
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: